ResMed (RMD) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

ResMed Revenue Highlights


Latest Revenue (Y)

$4.69B

Latest Revenue (Q)

$1.22B

Main Segment (Y)

Sleep And Respiratory

Main Geography (Y)

U [S]

ResMed Revenue by Period


ResMed Revenue by Year

DateRevenueChange
2024-06-30$4.69B10.95%
2023-06-30$4.22B18.02%
2022-06-30$3.58B11.93%
2021-06-30$3.20B8.11%
2020-06-30$2.96B13.44%
2019-06-30$2.61B11.38%
2018-06-30$2.34B13.23%
2017-06-30$2.07B12.40%
2016-06-30$1.84B9.52%
2015-06-30$1.68B7.97%
2014-06-30$1.55B2.68%
2013-06-30$1.51B10.66%
2012-06-30$1.37B10.08%
2011-06-30$1.24B13.80%
2010-06-30$1.09B18.64%
2009-06-30$920.74M10.22%
2008-06-30$835.40M16.62%
2007-06-30$716.33M18.01%
2006-06-30$607.00M42.65%
2005-06-30$425.50M25.39%
2004-06-30$339.34M24.04%
2003-06-30$273.57M34.05%
2002-06-30$204.08M31.53%
2001-06-30$155.16M34.20%
2000-06-30$115.61M30.49%
1999-06-30$88.60M33.23%
1998-06-30$66.50M35.16%
1997-06-30$49.20M42.20%
1996-06-30$34.60M47.23%
1995-06-30$23.50M69.06%
1994-06-30$13.90M80.52%
1993-06-30$7.70M-

ResMed generated $4.69B in revenue during NA 2024, up 10.95% compared to the previous quarter, and up 179.75% compared to the same period a year ago.

ResMed Revenue by Quarter

DateRevenueChange
2024-09-30$1.22B0.11%
2024-06-30$1.22B2.19%
2024-03-31$1.20B2.94%
2023-12-31$1.16B20.74%
2023-09-30$963.04M-14.17%
2023-06-30$1.12B0.46%
2023-03-31$1.12B8.04%
2022-12-31$1.03B8.78%
2022-09-30$950.29M3.89%
2022-06-30$914.74M5.81%
2022-03-31$864.50M-3.39%
2021-12-31$894.87M-1.01%
2021-09-30$904.01M3.19%
2021-06-30$876.10M13.96%
2021-03-31$768.77M-3.91%
2020-12-31$800.01M6.39%
2020-09-30$751.94M-2.39%
2020-06-30$770.34M0.12%
2020-03-31$769.46M4.52%
2019-12-31$736.16M8.09%
2019-09-30$681.06M-3.39%
2019-06-30$704.96M6.45%
2019-03-31$662.23M1.71%
2018-12-31$651.10M10.68%
2018-09-30$588.28M-5.67%
2018-06-30$623.63M5.41%
2018-03-31$591.63M-1.60%
2017-12-31$601.27M14.82%
2017-09-30$523.66M-5.93%
2017-06-30$556.69M8.26%
2017-03-31$514.20M-3.05%
2016-12-31$530.40M13.95%
2016-09-30$465.45M-10.26%
2016-06-30$518.65M14.27%
2016-03-31$453.88M-0.15%
2015-12-31$454.54M10.42%
2015-09-30$411.65M-9.14%
2015-06-30$453.06M7.23%
2015-03-31$422.50M-0.11%
2014-12-31$422.95M11.19%
2014-09-30$380.40M-8.38%
2014-06-30$415.21M4.39%
2014-03-31$397.76M3.49%
2013-12-31$384.34M7.46%
2013-09-30$357.66M-13.73%
2013-06-30$414.61M8.09%
2013-03-31$383.58M1.87%
2012-12-31$376.54M10.83%
2012-09-30$339.73M-8.66%
2012-06-30$371.93M6.55%
2012-03-31$349.07M4.91%
2011-12-31$332.74M5.71%
2011-09-30$314.77M-7.93%
2011-06-30$341.89M9.14%
2011-03-31$313.26M2.38%
2010-12-31$305.99M8.50%
2010-09-30$282.01M-3.28%
2010-06-30$291.57M4.63%
2010-03-31$278.66M1.28%
2009-12-31$275.13M11.39%
2009-09-30$246.99M-1.97%
2009-06-30$251.96M10.57%
2009-03-31$227.87M2.19%
2008-12-31$222.98M2.32%
2008-09-30$217.93M-7.32%
2008-06-30$235.15M11.01%
2008-03-31$211.83M-

ResMed generated $1.22B in revenue during Q1 2025, up 0.11% compared to the previous quarter, and up 109.13% compared to the same period a year ago.

ResMed Revenue Breakdown


ResMed Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceJun 23Jun 22Jun 21Jun 20Jun 19
Software As A Service$497.98M----
Software As Service$497.98M$400.83M$373.59M$354.63M$275.80M
Sleep And Respiratory$3.73B$3.18B$2.82B$2.60B-
Masks----$677.40M
Devices----$743.10M
Devices And Masks----$910.30M

ResMed's latest annual revenue breakdown by segment (product or service), as of Jun 23: Sleep And Respiratory (78.90%), Software As A Service (10.55%), and Software As Service (10.55%).

Quarterly Revenue by Product

Product/ServiceMar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19
Software As Service$147.96M$144.95M$139.28M$136.78M$116.76M$105.85M$101.14M$99.03M$97.52M$95.78M$91.48M$89.56M$86.71M$86.90M$85.20M$79.90M----
Sleep And Respiratory$1.05B$1.02B$963.04M$983.48M$980.12M$916.98M$844.44M$763.36M$795.84M$806.50M$780.33M$674.93M$708.18M$659.80M------
Devices And Masks--------------$678.87M$679.89M$649.45M$594.20M$619.80M$582.30M
Software As Service Before Deferred Revenue Adjustment--------------$91.48M$89.56M$87.36M$88.30M$86.20M$82.20M
Masks-------------------$245.80M
Devices-------------------$336.50M

ResMed's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Sleep And Respiratory (87.64%), and Software As Service (12.36%).

ResMed Revenue Breakdown by Country

Annual Revenue by Country

CountryJun 23Jun 22Jun 21Jun 20Jun 19
Global$1.50B$3.58B$3.20B$2.96B$2.61B
U [S]$2.72B----
Rest Of World$1.50B----
UNITED STATES$2.72B----
U.s. Canada And Latin America-$2.38B$2.08B$1.93B$1.70B

ResMed's latest annual revenue breakdown by geography, as of Jun 23: U [S] (32.20%), UNITED STATES (32.20%), Global (17.80%), and Rest Of World (17.80%).

Quarterly Revenue by Country

CountrySep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Jun 19Mar 19
Global$1.22B$1.20B$1.16B$1.10B$1.12B$136.78M$116.76M$105.85M$914.74M$101.14M$99.03M$97.52M$876.10M$93.84M$91.83M$92.14M$770.34M$89.56M$705.00M$79.90M
Us Canada And Latin America$707.31M$687.47M$669.33M$638.36M$257.07M$269.73M$105.85M$101.14M$99.03M$97.52M$93.84M$91.83M$92.14M$89.56M$79.90M-----
Combined Europe Asia And Other Markets$360.43M$361.55M$348.52M$324.68M$115.16M$104.45M$266.34M$287.93M$309.03M$315.46M$99.21M$93.42M$80.62M$91.31M$77.10M-----

ResMed's latest quarterly revenue breakdown by geography, as of Sep 24: Global (53.42%), Us Canada And Latin America (30.86%), and Combined Europe Asia And Other Markets (15.72%).

ResMed Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
BDXBecton, Dickinson and Company$19.37B$4.99B
BAXBaxter$14.81B$3.59B
ALCAlcon$10.09B$2.46B
RMDResMed$4.69B$1.22B
HOLXHologic$4.03B$1.01B
COOCooper Companies$3.59B$1.00B
TFXTeleflex$2.97B$764.38M
WSTWest Pharmaceutical Services$2.95B$746.90M
ICUIICU Medical$2.26B$596.46M
MMSIMerit Medical Systems$1.26B$339.85M
EMBCEmbecta$1.12B$272.50M
STAASTAAR Surgical Company$322.42K$88.59M

RMD Revenue FAQ


ResMed's yearly revenue for 2024 was $4.69B, representing an increase of 10.95% compared to 2023. The company's yearly revenue for 2023 was $4.22B, representing an increase of 18.02% compared to 2022. RMD's yearly revenue for 2022 was $3.58B, representing an increase of 11.93% compared to 2021.

ResMed's quarterly revenue for Q1 2025 was $1.22B, a 0.11% increase from the previous quarter (Q4 2024), and a 27.15% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $1.22B, a 2.19% increase from the previous quarter (Q3 2024), and a 9.01% increase year-over-year (Q4 2023). RMD's quarterly revenue for Q3 2024 was $1.2B, a 2.94% increase from the previous quarter (Q2 2024), and a 7.17% increase year-over-year (Q3 2023).

ResMed's revenue growth rate for the last 3 years (2022-2024) was 30.94%, and for the last 5 years (2020-2024) was 58.45%.

ResMed's revenue streams in n 23 are Software As A Service, Software As Service, and Sleep And Respiratory. Software As A Service generated $497.98M in revenue, accounting 10.55% of the company's total revenue Software As Service generated $497.98M in revenue, accounting 10.55% of the company's total revenue, up 24.24% year-over-year. Sleep And Respiratory generated $3.73B in revenue, accounting 78.90% of the company's total revenue, up 17.24% year-over-year.

For the fiscal year ending Jun 23, the largest source of revenue of ResMed was Sleep And Respiratory. This segment made a revenue of $3.73B, representing 78.90% of the company's total revenue.